{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:48:39Z","timestamp":1791359319019,"version":"4.3.1"},"reference-count":46,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: The spectrum of genetic variants and their clinical significance of Hypertrophic cardiomyopathy (HCM) have been poorly studied in Asian patients. The objectives of this study were to assess the spectrum of genetic variants and genotype\u2013phenotype relationships within a Korean HCM population. Methods: Eighty-nine consecutive unrelated HCM patients were included. All patients underwent genotypic analysis for 23 HCM-associated genes. Clinical parameters including echocardiographic and cardiac magnetic resonance (CMR) parameters were evaluated. A composite of major adverse cardiac and cerebrovascular events was assessed. Results: Genetic variants were detected in 55 of 89 subjects. Pathogenic variants or likely pathogenic variants were identified in 27 of HCM patients in MYBPC3, TNNI3, MYH7, and MYL7. Variants of uncertain significance were identified in 28 patients. There were significant differences in the presence of non-sustained ventricular tachycardia (p = 0.030) and myocardial fibrosis on CMR (p = 0.029) in the detected compared to the not-detected groups. Event-free survival was superior in the not-detected group (p = 0.006). Conclusion: Genetic variants in patients with HCM are relatively common and are associated with adverse clinical events and myocardial fibrosis on CMR. Genotypic analysis may add important information to clinical variables in the assessment of long-term risk for HCM patients.<\/jats:p>","DOI":"10.3390\/jcm9061671","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T09:19:27Z","timestamp":1591089567000},"page":"1671","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Genotype-Related Clinical Characteristics and Myocardial Fibrosis and Their Association with Prognosis in Hypertrophic Cardiomyopathy"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0692-5640","authenticated-orcid":false,"given":"Hyung Yoon","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Chonnam National University Medical School\/Hospital, Gwangju 61469, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Eun","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri 11923, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2176-0482","authenticated-orcid":false,"given":"Sang-Chol","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cardiovascular Imaging Center, Heart, Vascular &amp; Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Seok","family":"Jeon","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cardiovascular Imaging Center, Heart, Vascular &amp; Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Keun","family":"On","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cardiovascular Imaging Center, Heart, Vascular &amp; Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5190-2328","authenticated-orcid":false,"given":"Sung Mok","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Radiology, Cardiovascular Imaging Center, Heart, Vascular &amp; Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9983-048X","authenticated-orcid":false,"given":"Yeon Hyeon","family":"Choe","sequence":"additional","affiliation":[{"name":"Department of Radiology, Cardiovascular Imaging Center, Heart, Vascular &amp; Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Seok","family":"Ki","sequence":"additional","affiliation":[{"name":"Green Cross Genome, Yongin 16924, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Won","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6885-1501","authenticated-orcid":false,"given":"Kye Hun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Chonnam National University Medical School\/Hospital, Gwangju 61469, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,6,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0735-1097(03)00941-0","article-title":"American College of Cardiology\/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines","volume":"42","author":"Maron","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jacc.2009.02.075","article-title":"Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy","volume":"54","author":"Bos","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Burns, C., Bagnall, R.D., Lam, L., Semsarian, C., and Ingles, J. (2017). Multiple Gene Variants in Hypertrophic Cardiomyopathy in the Era of Next-Generation Sequencing. Circ. Cardiovasc. Genet., 10.","DOI":"10.1161\/CIRCGENETICS.116.001666"},{"key":"ref_4","first-page":"192","article-title":"Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples","volume":"19","author":"Walsh","year":"2017","journal-title":"Genet. Med. Off. J. Am. Coll. Med Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1016\/j.jacc.2016.08.079","article-title":"Clinical and Mechanistic Insights into the Genetics of Cardiomyopathy","volume":"68","author":"Burke","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_6","first-page":"880","article-title":"Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: Expanded panels offer limited additional sensitivity","volume":"17","author":"Alfares","year":"2015","journal-title":"Genet. Med. Off. J. Am. Coll. Med. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.hrthm.2011.05.020","article-title":"HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)","volume":"8","author":"Ackerman","year":"2011","journal-title":"Heart Rhythm"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1136\/heartjnl-2015-307682","article-title":"Myocardial fibrosis on cardiac magnetic resonance and cardiac outcomes in hypertrophic cardiomyopathy: A meta-analysis","volume":"101","author":"Briasoulis","year":"2015","journal-title":"Heart"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.jcmg.2016.02.031","article-title":"Prognostic Value of LGE-CMR in HCM: A Meta-Analysis","volume":"9","author":"Weng","year":"2016","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Williams, L.K., Frenneaux, M.P., and Steeds, R.P. (2009). Echocardiography in hypertrophic cardiomyopathy diagnosis, prognosis, and role in management. Eur. J. Echocardiogr. J. Work. Group Echocardiogr. Eur. Soc. Cardiol., 10.","DOI":"10.1093\/ejechocard\/jep157"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jtcvs.2011.10.019","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: Executive summary: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"142","author":"Gersh","year":"2011","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10554-008-9406-1","article-title":"Frequency and distribution of late gadolinium enhancement in magnetic resonance imaging of patients with apical hypertrophic cardiomyopathy and patients with asymmetrical hypertrophic cardiomyopathy: A comparative study","volume":"25","author":"Yamada","year":"2009","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"ref_14","unstructured":"(2018, May 05). Available online: http:\/\/gnomad.broadinstitute.org\/."},{"key":"ref_15","unstructured":"(2018, May 05). Available online: http:\/\/coda.nih.go.kr\/coda\/KRGDB\/index.jsp\/."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Viswanathan, S.K., Sanders, H.K., McNamara, J.W., Jagadeesan, A., Jahangir, A., Tajik, A.J., and Sadayappan, S. (2017). Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0187948"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy","volume":"121","author":"Marian","year":"2017","journal-title":"Circ. Res."},{"key":"ref_18","first-page":"405","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med. Off. J. Am. Coll. Med. Genet."},{"key":"ref_19","unstructured":"(2018, May 05). Available online: http:\/\/www.hgmd.org\/."},{"key":"ref_20","unstructured":"(2018, May 05). Available online: https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/."},{"key":"ref_21","unstructured":"(2018, May 05). Available online: http:\/\/sift.jcvi.org\/."},{"key":"ref_22","unstructured":"(2018, May 05). Available online: http:\/\/genetics.bwh.harvard.edu\/pph2\/."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1161\/01.CIR.82.6.1995","article-title":"Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy","volume":"82","author":"Frenneaux","year":"1990","journal-title":"Circulation"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0735-1097(02)01950-2","article-title":"Hemodynamic determinants of exercise-induced abnormal blood pressure response in hypertrophic cardiomyopathy","volume":"40","author":"Ciampi","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/S0735-1097(99)00094-7","article-title":"Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy","volume":"33","author":"Olivotto","year":"1999","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc0402.102975","article-title":"Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association","volume":"105","author":"Cerqueira","year":"2002","journal-title":"Circulation"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","article-title":"Recommendations for chamber quantification: A report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology","volume":"18","author":"Lang","year":"2005","journal-title":"J. Am. Soc. Echocardiogr. Off. Publ. Am. Soc. Echocardiogr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jacc.2012.02.068","article-title":"Genetics of hypertrophic cardiomyopathy after 20 years: Clinical perspectives","volume":"60","author":"Maron","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0025-6196(11)60890-2","article-title":"Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy","volume":"83","author":"Olivotto","year":"2008","journal-title":"Mayo Clin. Proc."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJM198911163212005","article-title":"Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1","volume":"321","author":"Jarcho","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"ref_31","first-page":"3461","article-title":"Defining the genetic architecture of hypertrophic cardiomyopathy: Re-evaluating the role of non-sarcomeric genes","volume":"38","author":"Walsh","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.gene.2015.11.048","article-title":"Molecular analysis of sarcomeric and non-sarcomeric genes in patients with hypertrophic cardiomyopathy","volume":"577","author":"Bottillo","year":"2016","journal-title":"Gene"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)","volume":"35","author":"Jichi","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_34","first-page":"30","article-title":"Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: A meta-analysis on 7675 individuals","volume":"107","author":"Kayvanpour","year":"2018","journal-title":"Clin. Res. Cardiol. Off. J. Ger. Card. Soc."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jacc.2011.05.018","article-title":"Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations","volume":"58","author":"Olivotto","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jacc.2004.04.039","article-title":"Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy","volume":"44","author":"Jaeger","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/CIRCGENETICS.112.963363","article-title":"Toronto hypertrophic cardiomyopathy genotype score for prediction of a positive genotype in hypertrophic cardiomyopathy","volume":"6","author":"Gruner","year":"2013","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jacc.2009.11.062","article-title":"Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations","volume":"55","author":"Girolami","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12265-017-9730-8","article-title":"Usefulness of Genetic Testing in Hypertrophic Cardiomyopathy: An Analysis Using Real-World Data","volume":"10","author":"Campuzano","year":"2017","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s00380-016-0920-0","article-title":"Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy","volume":"32","author":"Chida","year":"2017","journal-title":"Heart Vessel."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/jce.12948","article-title":"Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy","volume":"27","author":"Mc","year":"2016","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10554-007-9209-9","article-title":"Late hyperenhancement in gadolinium-enhanced magnetic resonance imaging: Comparison of hypertrophic cardiomyopathy patients with and without nonsustained ventricular tachycardia","volume":"24","author":"Dimitrow","year":"2008","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Weissler-Snir, A., Hindieh, W., Gruner, C., Fourey, D., Appelbaum, E., Rowin, E., Care, M., Lesser, J.R., Haas, T.S., and Udelson, J.E. (2017). Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (\u03b2-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy. Circ. Cardiovasc. Imaging, 10.","DOI":"10.1161\/CIRCIMAGING.116.005311"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Miller, R.J.H., Heidary, S., Pavlovic, A., Schlachter, A., Dash, R., Fleischmann, D., Ashley, E.A., Wheeler, M.T., and Yang, P.C. (2019). Defining genotype-phenotype relationships in patients with hypertrophic cardiomyopathy using cardiovascular magnetic resonance imaging. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0217612"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1161\/CIRCULATIONAHA.117.029267","article-title":"Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy","volume":"136","author":"Rowin","year":"2017","journal-title":"Circulation"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10741-018-9752-6","article-title":"Atrial fibrillation in hypertrophic cardiomyopathy: Prevalence, clinical impact, and management","volume":"24","author":"Garg","year":"2019","journal-title":"Heart Fail. Rev."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/6\/1671\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:34:39Z","timestamp":1760175279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/6\/1671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,1]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["jcm9061671"],"URL":"https:\/\/doi.org\/10.3390\/jcm9061671","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,1]]}}}